Swami U - Search Results

1

Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data.

Swami U, Aggarwal H, Zhou M, Jiang S, Kim J, Li W, Laliberté F, Emond B, Agarwal N. Swami U, et al. Clin Genitourin Cancer. 2023 Oct;21(5):517-529. doi: 10.1016/j.clgc.2023.04.014. Epub 2023 May 3. Clin Genitourin Cancer. 2023. PMID: 37248148

2

Gastrointestinal stromal tumors-are we stuck and the way forward.

Swami U, Monga V, Milhem M. Swami U, et al. Transl Gastroenterol Hepatol. 2017 Nov 20;2:93. doi: 10.21037/tgh.2017.11.07. eCollection 2017. Transl Gastroenterol Hepatol. 2017. PMID: 29264431 Free PMC article. No abstract available.

3

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.

Swami U, Monga V, Freesmeier M, Zhang W, Bossler AD, Zakharia Y, Milhem M. Swami U, et al. Melanoma Res. 2019 Dec;29(6):643-647. doi: 10.1097/CMR.0000000000000592. Melanoma Res. 2019. PMID: 30829928 Free PMC article.

4

Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion.

Swami U, Ma D, Zhang J. Swami U, et al. J Thorac Oncol. 2018 Jul;13(7):e129-e130. doi: 10.1016/j.jtho.2018.03.034. J Thorac Oncol. 2018. PMID: 29935854 Free article. No abstract available.

5

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.

Zakharia Y, Monga V, Swami U, Bossler AD, Freesmeier M, Frees M, Khan M, Frydenlund N, Srikantha R, Vanneste M, Henry M, Milhem M. Zakharia Y, et al. Among authors: swami u. Oncotarget. 2017 Sep 26;8(51):89182-89193. doi: 10.18632/oncotarget.21269. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179510 Free PMC article.

6

Advanced stage melanoma therapies: Detailing the present and exploring the future.

Luther C, Swami U, Zhang J, Milhem M, Zakharia Y. Luther C, et al. Among authors: swami u. Crit Rev Oncol Hematol. 2019 Jan;133:99-111. doi: 10.1016/j.critrevonc.2018.11.002. Epub 2018 Nov 15. Crit Rev Oncol Hematol. 2019. PMID: 30661664 Review.

7

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together.

Swami U, Zakharia Y, Zhang J. Swami U, et al. J Immunother. 2018 Oct;41(8):359-360. doi: 10.1097/CJI.0000000000000232. J Immunother. 2018. PMID: 29781826 Review.

8

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas.

Monga V, Swami U, Tanas M, Bossler A, Mott SL, Smith BJ, Milhem M. Monga V, et al. Among authors: swami u. Cancers (Basel). 2018 Feb 17;10(2):53. doi: 10.3390/cancers10020053. Cancers (Basel). 2018. PMID: 29462961 Free PMC article.

9

Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer.

Mani S, Swami U. Mani S, et al. Among authors: swami u. Drugs Today (Barc). 2010 Sep;46(9):641-53. doi: 10.1358/dot.2010.46.9.1519020. Drugs Today (Barc). 2010. PMID: 20967296

10

Immunotherapy and fatigue: what we know and what we don't know.

Azeem Khan M, Florou V, Swami U. Azeem Khan M, et al. Among authors: swami u. Oncotarget. 2021 Apr 13;12(8):719-720. doi: 10.18632/oncotarget.27946. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889294 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters